“On March 28, 2020, the FDA issued an Emergency Use Authorization (EUA) to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile(SNS) to be distributed and used for certain hospitalized patients with COVID-19. These drugs will be distributed from the SNS to states for doctors to prescribe to adolescent and adult patients hospitalized with COVID-19, as appropriate, when a clinical trial is not available or feasible. “
________________________________________________________________________
This was the Strategic National Stockpile drugs and per this is for “hospitalized” patients. Haven’t seen any changes to this action for outpatient use yet.
Not saying I agree with only in hospital use, but . . .
[[prescribe to adolescent and adult patients hospitalized with COVID-19, as appropriate,]]
“As Appropriate” is a very broad blanket- open to interpretation- people are dying without it- they aren’t even being given the consideration of whether their early case requires ‘appropriate treatment’